KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palvella Therapeutics (PVLA) Assets Average (2016 - 2026)

Palvella Therapeutics has reported Assets Average over the past 9 years, most recently at $97.3 million for Q4 2022.

  • Quarterly Assets Average fell 38.74% to $97.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $97.3 million through Dec 2022, down 38.74% year-over-year, with the annual reading at $124.5 million for FY2022, 3.68% down from the prior year.
  • Assets Average was $97.3 million for Q4 2022 at Palvella Therapeutics, down from $106.7 million in the prior quarter.
  • Over five years, Assets Average peaked at $167.6 million in Q2 2018 and troughed at $97.3 million in Q4 2022.
  • The 5-year median for Assets Average is $131.7 million (2019), against an average of $132.5 million.
  • Year-over-year, Assets Average surged 185.87% in 2018 and then crashed 38.74% in 2022.
  • A 5-year view of Assets Average shows it stood at $146.5 million in 2018, then decreased by 12.0% to $128.9 million in 2019, then fell by 14.39% to $110.4 million in 2020, then soared by 43.95% to $158.9 million in 2021, then crashed by 38.74% to $97.3 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Assets Average are $97.3 million (Q4 2022), $106.7 million (Q3 2022), and $125.7 million (Q2 2022).